Free Trial

Acelyrin (SLRN) News Today

Acelyrin logo
$2.17 -0.08 (-3.56%)
As of 04/24/2025 04:00 PM Eastern
Acelyrin, Inc. stock logo
Acelyrin, Inc. (NASDAQ:SLRN) Short Interest Update
Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 3,650,000 shares, a decline of 22.0% from the March 15th total of 4,680,000 shares. Based on an average trading volume of 2,170,000 shares, the days-to-cover ratio is presently 1.7 days. Currently, 5.0% of the company's stock are short sold.
Alumis and ACELYRIN Announce Amended Merger Agreement
Acelyrin, Inc. stock logo
Wellington Management Group LLP Buys New Shares in Acelyrin, Inc. (NASDAQ:SLRN)
Wellington Management Group LLP purchased a new position in shares of Acelyrin, Inc. (NASDAQ:SLRN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 180,539 shares of the
Acelyrin, Inc. stock logo
ExodusPoint Capital Management LP Takes $423,000 Position in Acelyrin, Inc. (NASDAQ:SLRN)
ExodusPoint Capital Management LP purchased a new position in Acelyrin, Inc. (NASDAQ:SLRN - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 134,680 shares of the comp
Acelyrin, Inc. stock logo
ADAR1 Capital Management LLC Acquires 391,467 Shares of Acelyrin, Inc. (NASDAQ:SLRN)
ADAR1 Capital Management LLC lifted its stake in shares of Acelyrin, Inc. (NASDAQ:SLRN - Free Report) by 731.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 444,967 shares of the company's stock after acquiring an additional 391
Acelyrin, Inc. stock logo
Insider Selling: Acelyrin, Inc. (NASDAQ:SLRN) Insider Sells 3,913 Shares of Stock
Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) insider Amar Murugan sold 3,913 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $2.74, for a total transaction of $10,721.62. Following the transaction, the insider now directly owns 121,587 shares in the company, valued at approximately $333,148.38. The trade was a 3.12 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Acelyrin, Inc. stock logo
Insider Selling: Acelyrin, Inc. (NASDAQ:SLRN) CEO Sells 17,986 Shares of Stock
Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) CEO Mina Kim sold 17,986 shares of the firm's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $2.74, for a total transaction of $49,281.64. Following the completion of the transaction, the chief executive officer now directly owns 671,753 shares in the company, valued at $1,840,603.22. This represents a 2.61 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Acelyrin (NASDAQ:SLRN - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.79) earnings per share for the quarter, beating analysts' consensus estimates of ($0.86) by $0.07.
Acelyrin, Inc. stock logo
Acelyrin (SLRN) Projected to Post Quarterly Earnings on Thursday
Acelyrin (NASDAQ:SLRN) will be releasing earnings before the market opens on Thursday, March 27, Financial Modeling Prep reports.
Acelyrin, Inc. stock logo
Acelyrin, Inc. (NASDAQ:SLRN) Holdings Decreased by General Atlantic L.P.
General Atlantic L.P. trimmed its position in Acelyrin, Inc. (NASDAQ:SLRN - Free Report) by 6.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,695,327 shares of the company's stock after selling 194,341 shares during the
Acelyrin, Inc. stock logo
Acelyrin, Inc. (NASDAQ:SLRN) Sees Large Decrease in Short Interest
Acelyrin, Inc. (NASDAQ:SLRN - Get Free Report) saw a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 4,720,000 shares, a decrease of 19.6% from the January 31st total of 5,870,000 shares. Currently, 6.5% of the shares of the company are short sold. Based on an average trading volume of 1,930,000 shares, the days-to-cover ratio is currently 2.4 days.
Acelyrin, Inc. stock logo
Acelyrin (NASDAQ:SLRN) Stock Price Up 1.2% - Should You Buy?
Acelyrin (NASDAQ:SLRN) Shares Up 1.2% - Still a Buy?
Acelyrin Stock Jumps on Concentra Acquisition Interest
Acelyrin Stock Jumps on Concentra Acquisition Interest
Alumis price target lowered to $26 from $32 at Oppenheimer
Piper Sandler Sticks to Their Buy Rating for ACELYRIN, INC. (SLRN)
ACELYRIN, INC. (SLRN) Receives a Buy from Wells Fargo
Acelyrin Inc trading halted, news pending
Alumis and ACELYRIN Agree to Merge in All-Stock Deal
Alumis, Acelyrin to merge in all-stock transaction
Acelyrin, Inc. stock logo
JPMorgan Chase & Co. Cuts Stake in Acelyrin, Inc. (NASDAQ:SLRN)
JPMorgan Chase & Co. lowered its stake in shares of Acelyrin, Inc. (NASDAQ:SLRN - Free Report) by 67.3% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 850,661 shares of the company's stock after selling 1,747,642 shares during the quarter. JP
Acelyrin, Inc. stock logo
What is HC Wainwright's Estimate for Acelyrin Q1 Earnings?
Acelyrin, Inc. (NASDAQ:SLRN - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for shares of Acelyrin in a research note issued on Tuesday, January 7th. HC Wainwright analyst E. Bodnar anticipates that the company will earn ($0.44) per s
Get Acelyrin News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLRN and its competitors with MarketBeat's FREE daily newsletter.

SLRN Media Mentions By Week

SLRN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SLRN
News Sentiment

0.96

0.73

Average
Medical
News Sentiment

SLRN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SLRN Articles
This Week

2

3

SLRN Articles
Average Week

Get Acelyrin News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLRN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SLRN) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners